Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2017 | 03-2016 | 03-2015 | 03-2007 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -180,951 | -133,145 | 0 | N/A |
| Depreciation Amortization | 249 | 14 | 0 | N/A |
| Income taxes - deferred | -2,386 | -323 | N/A | N/A |
| Accounts payable and accrued liabilities | 7,929 | 219 | N/A | N/A |
| Other Working Capital | 34,231 | 2,469 | 0 | N/A |
| Other Operating Activity | 28,819 | 77,419 | 0 | 0 |
| Operating Cash Flow | $-112,109 | $-53,347 | $0 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -105 | -94 | 0 | N/A |
| Other Investing Activity | 0 | -5,252 | 0 | 0 |
| Investing Cash Flow | $-105 | $-5,346 | $0 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 53,500 | N/A | N/A | N/A |
| Common Stock Issued | 36 | 336,893 | N/A | N/A |
| Other Financing Activity | -5,000 | -1,949 | 0 | 0 |
| Financing Cash Flow | $48,536 | $334,944 | $0 | $N/A |
| Beginning Cash Position | 276,251 | N/A | 0 | N/A |
| End Cash Position | 212,573 | 276,251 | 0 | N/A |
| Net Cash Flow | $-63,678 | $276,251 | $0 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -112,109 | -53,347 | 0 | N/A |
| Capital Expenditure | -105 | -94 | N/A | N/A |
| Free Cash Flow | -112,214 | -53,441 | 0 | 0 |